CollPlant is a clinical stage regenerative Medicine Company focused on developing and commercializing tissue repair products, initially for orthobiologics and advanced wound care markets. Our products are based on our rhCollagen (recombinant human collagen) that is produced with CollPlant’s proprietary plant based genetic engineering technology.
Our product candidates address indications for diverse fields of tissue repair and are ushering in a new era in regenerative medicine. Our flagship Vergenix line of rhCollagen products include a surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds.
We strive to be the leading company in the field of regenerative medicine by delivering innovative tissue repair products that offer the best treatment options to patients and their physicians.